Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Decreases By 16.7%

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 1,620,800 shares, a decline of 16.7% from the January 31st total of 1,946,100 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 16,208.0 days.

Ascentage Pharma Group International Price Performance

Ascentage Pharma Group International stock opened at $5.83 on Thursday. Ascentage Pharma Group International has a fifty-two week low of $5.42 and a fifty-two week high of $6.45. The stock’s fifty day moving average is $6.04 and its two-hundred day moving average is $5.15.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.